|
PSMG4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.53129731117474E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.98599999778892E-08 |
| Normal-vs-Stage2 |
3.876300E-03 |
| Normal-vs-Stage3 |
1.52653999999641E-05 |
| Normal-vs-Stage4 |
1.58657000000062E-05 |
| Stage1-vs-Stage2 |
4.117000E-01 |
| Stage1-vs-Stage3 |
8.651200E-01 |
| Stage1-vs-Stage4 |
3.192000E-02 |
| Stage2-vs-Stage3 |
4.800400E-01 |
| Stage2-vs-Stage4 |
3.989600E-01 |
| Stage3-vs-Stage4 |
5.240200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.99369973255637E-10 |
| Normal-vs-AfricanAmerican |
2.99390000002564E-06 |
| Normal-vs-Asian |
4.100400E-01 |
| Caucasian-vs-AfricanAmerican |
1.309670E-02 |
| Caucasian-vs-Asian |
7.432800E-01 |
| AfricanAmerican-vs-Asian |
2.876000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.617100003377E-08 |
| Normal-vs-Female |
4.27630153509995E-11 |
| Male-vs-Female |
1.022230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.260240E-02 |
| Normal-vs-Age(41-60Yrs) |
4.54140000050174E-08 |
| Normal-vs-Age(61-80Yrs) |
6.99970004180983E-09 |
| Normal-vs-Age(81-100Yrs) |
7.082100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.017600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.005600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.641960E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.243400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.775210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.531580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.467700E-02 |
| Normal-vs-Grade 2 |
1.8906999965651E-08 |
| Normal-vs-Grade 3 |
5.47159995090141E-09 |
| Normal-vs-Grade 4 |
1.960790E-03 |
| Grade 1-vs-Grade 2 |
8.543000E-01 |
| Grade 1-vs-Grade 3 |
9.254800E-01 |
| Grade 1-vs-Grade 4 |
8.904000E-01 |
| Grade 2-vs-Grade 3 |
7.876600E-01 |
| Grade 2-vs-Grade 4 |
6.367400E-01 |
| Grade 3-vs-Grade 4 |
7.379800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.71849998068063E-09 |
| Normal-vs-ccB subtype |
1.247660E-02 |
| ccA subtype-vs-ccB subtype |
2.454400E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.77909999954373E-07 |
| Normal-vs-N1 |
1.666240E-01 |
| N0-vs-N1 |
7.239000E-01 |
|
|
